Do Resistance Consequences of Initial Treatment Regimens Favor Boosted PI-containing Regimens over NNRTI-containing Regimens? - 3/17/06

Report on the XIV International HIV Drug Resistance Workshop: Parts 1-3 - 7/06/05

Differences in Enhanced Susceptibilities to NNRTIs and to Zidovudine in Site-directed Mutants (SDMs) Bearing K65R, L74V or M184V - 6/15/05

Body Fat Changes in Treatment-naive Patients on PI- and NNRTI-based HAART in the Swiss HIV Cohort Study: Fat Loss More Likely with Increasing Stavudine Use - 5/23/05

Effect of Depomedroxyprogesterone Acetate (DMPA) on the Pharmacokinetics of PI and NNRTI Therapies Among HIV Positive Women - 3/16/05

Results of Phase 1 Study of Experimental NNRTI Capravirine - 11/29/04

NNRTI-based HAART May Lead to More Stable Therapy - 10/15/04

Long-Term Efficacy and Safety of Switch from Protease Inhibitor to NNRTI Nevirapine in Patients with Undetectable HIV Viral Load - 09/22/04

The Impact of Initial HAART on Future Treatment Sequences in HIV Infection - 9/15/04